I agree that this site is using cookies. You can find further informations here.
X
Manzoor, Beenish S.
66  results:
Search for persons X
?
1

Venetoclax-Obinutuzumab for previously untreated chronic ly..:

Al-Sawaf, Othman ; Robrecht, Sandra ; Zhang, Can...
Blood Journal.  , 2024
Link: https://doi.org/10.1182/..
 
?
2

Real‐world comparative effectiveness of venetoclax‐obinutuz..:

Ghosh, Nilanjan ; Manzoor, Beenish S. ; Fakhri, Bita...
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
3

Treatment Discontinuation Patterns for Patients With Chroni..:

Shadman, Mazyar ; Manzoor, Beenish S. ; Sail, Kavita...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  7 - p. 515-526 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Real-world adherence and discontinuation among Medicare ben..:

Huntington, Scott F. ; Manzoor, Beenish S. ; Puckett, Justin T....
Leukemia & Lymphoma.  64 (2023)  14 - p. 2316-2323 , 2023
Link: https://doi.org/10.1080/..
 
?
5

Venetoclax retreatment of patients with chronic lymphocytic..:

Thompson, Meghan C. ; Harrup, Rosemary A. ; Coombs, Catherine C....
Blood Advances.  6 (2022)  15 - p. 4553-4557 , 2022
Link: https://doi.org/10.1182/..
 
?
6

A Probabilistic Cost-Effectiveness Analysis of Venetoclax a..:

Chatterjee, Anuja ; van de Wetering, Gijs ; Goeree, Ron...
PharmacoEconomics - Open.  7 (2022)  2 - p. 199-216 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Poster: CLL-410 Adherence and Discontinuation Among Medicar..:

Huntington, Scott F ; Manzoor, Beenish S ; Puckett, Justin T...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S143 , 2022
Link: https://doi.org/10.1016/..
 
?
8

CLL-410 Adherence and Discontinuation Among Medicare Benefi..:

Huntington, Scott F ; Manzoor, Beenish S ; Puckett, Justin T...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S277-S278 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Budget Impact of 12-Month Fixed Treatment Duration Venetocl..:

Cho, Sang Kyu ; Manzoor, Beenish S. ; Sail, Kavita R....
PharmacoEconomics.  38 (2020)  9 - p. 941-951 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Facilitators and Barriers to the Adoption of Pharmacogeneti..:

Lee, Yee Ming ; Manzoor, Beenish S. ; Cavallari, Larisa H..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  38 (2018)  2 - p. 205-216 , 2018
Link: https://doi.org/10.1002/..
 
?
11

Outcomes of systematic anticoagulation management in pharma..:

Manzoor, Beenish S. ; Bauman, Jerry ; Shapiro, Nancy L....
JACCP:JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.  1 (2018)  2 - p. 68-73 , 2018
Link: https://doi.org/10.1002/..
 
?
12

Quality of Pharmacist-Managed Anticoagulation Therapy in Lo..:

Manzoor, Beenish S. ; Cheng, Wei-Han ; Lee, James C...
Annals of Pharmacotherapy.  51 (2017)  12 - p. 1122-1137 , 2017
Link: https://doi.org/10.1177/..
 
?
13

High number of newly initiated direct oral anticoagulant us..:

Manzoor, Beenish S. ; Walton, Surrey M. ; Sharp, Lisa K....
Journal of Thrombosis and Thrombolysis.  44 (2017)  4 - p. 435-441 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Real‐World Adherence and Persistence with Direct Oral Antic..:

Manzoor, Beenish S. ; Lee, Todd A. ; Sharp, Lisa K....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.  37 (2017)  10 - p. 1221-1230 , 2017
Link: https://doi.org/10.1002/..
 
?
15

Drug–Alcohol Interactions in Older U.S. Adults:

Qato, Dima Mazen ; Manzoor, Beenish S. ; Lee, Todd A.
Journal of the American Geriatrics Society.  63 (2015)  11 - p. 2324-2331 , 2015
Link: https://doi.org/10.1111/..
 
1-15